12:00 AM
 | 
Oct 29, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Homologous Recombination Deficiency diagnostic data

An analysis of 639 ovarian tumor samples and 57 breast and pancreatic cancer cell lines showed that high HRD scores, defined as the number of defective BRCA1 and BRCA2 regions in a tumor sample as measured by Myriad Genetics' HRD...

Read the full 176 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >